MDS' Q3 Revenues Drop Amid Sale of Analytical Technologies Unit

MDS' revenues fell 21 percent as it proceeds with the sale of its Analytical Technologies unit to Danaher.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.